Cargando…
Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India
Navi Mumbai Municipal Corporation (NMMC), a local government in Mumbai, India, implemented the first public sector TCV campaign in 2018. This study estimated the delivery costs of this TCV campaign using a Microsoft Excel-based tool based on a micro-costing approach from the government (NMMC) perspe...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022355/ https://www.ncbi.nlm.nih.gov/pubmed/36962873 http://dx.doi.org/10.1371/journal.pgph.0001396 |
_version_ | 1784908713080913920 |
---|---|
author | Song, Dayoung Pallas, Sarah W. Shimpi, Rahul Ramaswamy, N. Haldar, Pradeep Harvey, Pauline Bhatnagar, Pankaj Katkar, Arun Jayaprasad, Niniya Kunwar, Abhishek Bahl, Sunil Morgan, Win Hutubessy, Raymond Date, Kashmira Mogasale, Vittal |
author_facet | Song, Dayoung Pallas, Sarah W. Shimpi, Rahul Ramaswamy, N. Haldar, Pradeep Harvey, Pauline Bhatnagar, Pankaj Katkar, Arun Jayaprasad, Niniya Kunwar, Abhishek Bahl, Sunil Morgan, Win Hutubessy, Raymond Date, Kashmira Mogasale, Vittal |
author_sort | Song, Dayoung |
collection | PubMed |
description | Navi Mumbai Municipal Corporation (NMMC), a local government in Mumbai, India, implemented the first public sector TCV campaign in 2018. This study estimated the delivery costs of this TCV campaign using a Microsoft Excel-based tool based on a micro-costing approach from the government (NMMC) perspective. The campaign’s financial (direct expenditures) and economic costs (financial costs plus the monetized value of additional donated or existing items) incremental to the existing immunization program were collected. The data collection methods involved consultations with NMMC staff, reviews of financial and programmatic records of NMMC and the World Health Organization (WHO), and interviews with the health staff of sampled urban health posts (UHPs). Three UHPs were purposively sampled, representing the three dominant residence types in the catchment area: high-rise, slum, and mixed (high-rise and slum) areas. The high-rise area UHP had lower vaccination coverage (47%) compared with the mixed area (71%) and slum area UHPs (76%). The financial cost of vaccine and vaccination supplies (syringes, safety boxes) was $1.87 per dose, and the economic cost was $2.96 per dose in 2018 US dollars. Excluding the vaccine and vaccination supplies cost, the financial delivery cost across the 3 UHPs ranged from $0.37 to $0.53 per dose, and the economic delivery cost ranged from $1.37 to $3.98 per dose, with the highest delivery costs per dose in the high-rise areas. Across all 11 UHPs included in the campaign, the weighted average financial delivery cost was $0.38 per dose, and the economic delivery cost was $1.49 per dose. WHO has recommended the programmatic use of TCV in typhoid-endemic countries, and Gavi has included TCV in its vaccine portfolio. This first costing study of large-scale TCV introduction within a public sector immunization program provides empirical evidence for policymakers, stakeholders, and future vaccine campaign planning. |
format | Online Article Text |
id | pubmed-10022355 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-100223552023-03-17 Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India Song, Dayoung Pallas, Sarah W. Shimpi, Rahul Ramaswamy, N. Haldar, Pradeep Harvey, Pauline Bhatnagar, Pankaj Katkar, Arun Jayaprasad, Niniya Kunwar, Abhishek Bahl, Sunil Morgan, Win Hutubessy, Raymond Date, Kashmira Mogasale, Vittal PLOS Glob Public Health Research Article Navi Mumbai Municipal Corporation (NMMC), a local government in Mumbai, India, implemented the first public sector TCV campaign in 2018. This study estimated the delivery costs of this TCV campaign using a Microsoft Excel-based tool based on a micro-costing approach from the government (NMMC) perspective. The campaign’s financial (direct expenditures) and economic costs (financial costs plus the monetized value of additional donated or existing items) incremental to the existing immunization program were collected. The data collection methods involved consultations with NMMC staff, reviews of financial and programmatic records of NMMC and the World Health Organization (WHO), and interviews with the health staff of sampled urban health posts (UHPs). Three UHPs were purposively sampled, representing the three dominant residence types in the catchment area: high-rise, slum, and mixed (high-rise and slum) areas. The high-rise area UHP had lower vaccination coverage (47%) compared with the mixed area (71%) and slum area UHPs (76%). The financial cost of vaccine and vaccination supplies (syringes, safety boxes) was $1.87 per dose, and the economic cost was $2.96 per dose in 2018 US dollars. Excluding the vaccine and vaccination supplies cost, the financial delivery cost across the 3 UHPs ranged from $0.37 to $0.53 per dose, and the economic delivery cost ranged from $1.37 to $3.98 per dose, with the highest delivery costs per dose in the high-rise areas. Across all 11 UHPs included in the campaign, the weighted average financial delivery cost was $0.38 per dose, and the economic delivery cost was $1.49 per dose. WHO has recommended the programmatic use of TCV in typhoid-endemic countries, and Gavi has included TCV in its vaccine portfolio. This first costing study of large-scale TCV introduction within a public sector immunization program provides empirical evidence for policymakers, stakeholders, and future vaccine campaign planning. Public Library of Science 2023-01-04 /pmc/articles/PMC10022355/ /pubmed/36962873 http://dx.doi.org/10.1371/journal.pgph.0001396 Text en https://creativecommons.org/publicdomain/zero/1.0/This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication. |
spellingShingle | Research Article Song, Dayoung Pallas, Sarah W. Shimpi, Rahul Ramaswamy, N. Haldar, Pradeep Harvey, Pauline Bhatnagar, Pankaj Katkar, Arun Jayaprasad, Niniya Kunwar, Abhishek Bahl, Sunil Morgan, Win Hutubessy, Raymond Date, Kashmira Mogasale, Vittal Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India |
title | Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India |
title_full | Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India |
title_fullStr | Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India |
title_full_unstemmed | Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India |
title_short | Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India |
title_sort | delivery cost of the first public sector introduction of typhoid conjugate vaccine in navi mumbai, india |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022355/ https://www.ncbi.nlm.nih.gov/pubmed/36962873 http://dx.doi.org/10.1371/journal.pgph.0001396 |
work_keys_str_mv | AT songdayoung deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia AT pallassarahw deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia AT shimpirahul deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia AT ramaswamyn deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia AT haldarpradeep deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia AT harveypauline deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia AT bhatnagarpankaj deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia AT katkararun deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia AT jayaprasadniniya deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia AT kunwarabhishek deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia AT bahlsunil deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia AT morganwin deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia AT hutubessyraymond deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia AT datekashmira deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia AT mogasalevittal deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia |